Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Robinson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2021
PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesisLili Pan, Chao Hong, Lai N Chan, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Dynamic phosphatase-recruitment controls B-cell selection and oncogenic signalingJaewoong Lee, Mark E Robinson, Ruifeng Sun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 1, 2026
BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting DrugsHan Leng Ng, Trudy Lee Glaser, Jintao Zhu, et al.
Oncogene|January 11, 2019
The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitationKatarzyna Parzych, Paula Saavedra-García, Gabriel N Valbuena, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Targeted engagement of β-catenin-Ikaros complexes in refractory B-cell malignanciesKadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson, et al.
Nature Cancer|January 8, 2026
Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemiaKadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson, et al.
Molecular Cell|April 20, 2021
Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancerTeresa Sadras, Mickaël Martin, Kohei Kume, et al.
Nature|July 24, 2020
Signalling input from divergent pathways subverts B cell transformationLai N Chan, Mark A Murakami, Mark E Robinson, et al.
Nature|March 13, 2021
Author Correction: IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cellsJaewoong Lee, Mark E Robinson, Ning Ma, et al.
Nature|November 5, 2020
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cellsJaewoong Lee, Mark E Robinson, Ning Ma, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2021
PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesisLili Pan, Chao Hong, Lai N Chan, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Dynamic phosphatase-recruitment controls B-cell selection and oncogenic signalingJaewoong Lee, Mark E Robinson, Ruifeng Sun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 1, 2026
BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting DrugsHan Leng Ng, Trudy Lee Glaser, Jintao Zhu, et al.
Oncogene|January 11, 2019
The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitationKatarzyna Parzych, Paula Saavedra-García, Gabriel N Valbuena, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Targeted engagement of β-catenin-Ikaros complexes in refractory B-cell malignanciesKadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson, et al.
Nature Cancer|January 8, 2026
Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemiaKadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson, et al.
Molecular Cell|April 20, 2021
Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancerTeresa Sadras, Mickaël Martin, Kohei Kume, et al.
Nature|July 24, 2020
Signalling input from divergent pathways subverts B cell transformationLai N Chan, Mark A Murakami, Mark E Robinson, et al.
Nature|March 13, 2021
Author Correction: IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cellsJaewoong Lee, Mark E Robinson, Ning Ma, et al.
Nature|November 5, 2020
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cellsJaewoong Lee, Mark E Robinson, Ning Ma, et al.
Pageof 3